Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Qiagen N.V.    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

QIAGEN N.V. : Notification and public disclosure of transactions by persons

share with twitter share with LinkedIn share with facebook
09/14/2020 | 04:35pm EDT


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

14.09.2020 / 22:30
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title: Prof. Dr.
First name: Elaine R.
Last name(s): Mardis

2. Reason for the notification

a) Position / status
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
QIAGEN N.V.

b) LEI
54930036WK3GMCN17Z57 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: NL0012169213

b) Nature of the transaction
Disposal

c) Price(s) and volume(s)
Price(s) Volume(s)
49.4765 USD 147341.02 USD

d) Aggregated information
Price Aggregated volume
49.4765 USD 147341.0200 USD

e) Date of the transaction
2020-09-09; UTC+2

f) Place of the transaction
Name: New York Stock Exchange
MIC: XNYS



14.09.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: QIAGEN N.V.
Hulsterweg 82
5912 PL Venlo
Netherlands
Internet: www.qiagen.com

 
End of News DGAP News Service

62723  14.09.2020 

© EQS 2020

share with twitter share with LinkedIn share with facebook
All news about QIAGEN N.V.
10/14QIAGEN NV : Kepler Cheuvreux maintains a Buy rating
MD
10/13QIAGEN NV : Jefferies remains Neutral
MD
10/13QIAGEN N : reports strong preliminary results for third quarter of 2020
BU
10/13QIAGEN N.V. : QIAGEN reports strong preliminary results for third quarter of 202..
EQ
10/09QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German..
EQ
10/05QIAGEN : to Complement COVID-19 Testing Portfolio With Novel Kit That Simplifies..
BU
09/18QIAGEN NV : Warburg Research reiterates its Neutral rating
MD
09/17QIAGEN N : fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR..
BU
09/15QIAGEN NV : DZ Bank reiterates its Neutral rating
MD
09/14QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
More news
Financials (USD)
Sales 2020 1 802 M - -
Net income 2020 326 M - -
Net Debt 2020 1 017 M - -
P/E ratio 2020 37,4x
Yield 2020 -
Capitalization 11 961 M 11 961 M -
EV / Sales 2020 7,20x
EV / Sales 2021 6,20x
Nbr of Employees 5 200
Free-Float 92,9%
Chart QIAGEN N.V.
Duration : Period :
Qiagen N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QIAGEN N.V.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 55,82 $
Last Close Price 52,29 $
Spread / Highest target 26,2%
Spread / Average Target 6,75%
Spread / Lowest Target -27,3%
EPS Revisions
Managers
NameTitle
Thierry Bernard Chief Executive Officer
Lawrence A. Rosen Chairman-Supervisory Board
Barthold Piening Senior Vice President & Head-Global Operations
Roland Sackers Chief Financial Officer & Managing Director
Metin Colpan Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
QIAGEN N.V.54.79%11 968
LONZA GROUP AG69.31%48 545
SEAGEN INC.75.85%34 961
IQVIA HOLDINGS INC.6.50%31 476
CELLTRION, INC.41.16%30 032
MODERNA, INC.278.02%29 176